Skip to content
Agentic OS
Menu

Intelligence / Healthtech / New Clinical Trials / Aqua Therapeutics, Inc.

Clinicaltrial registered9 Nov 2026

Aqua Therapeutics, Inc.

9 Nov 2026: Trial registered · Clinical Study on the Safety and the Performance of an Endometrial Ablation System in Women With Abnormal Uterine Bleeding (AUB) and Previous Cesarean Delivery. Recorded in the ClinicalTrials.gov (US National Library of Medicine).

View the source record

Posted
9 Nov 2026
Title
Clinical Study on the Safety and the Performance of an Endometrial Ablation System in Women With Abnormal Uterine Bleeding (AUB) and Previous Cesarean Delivery
Conditions
Menorrhagia
Phase
Not applicable
Study Type
Interventional
Status
Recruiting
Countries
Austria, Italy
Country
Austria
Reference
NCT07925008
Location
Austria, Italy
What this signal means

A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.

  1. United States leads with 192 of 777, then China (171).
  2. 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS

Find the decision makers at Aqua Therapeutics, Inc.

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.

Start free

More from Austria

New Clinical Trials

See all

Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.